ABT

Gilead vs. Abbott: Which Dividend Healthcare Stock Offers the Better Risk-Reward?

Abbott (ABT) Registers a Bigger Fall Than the Market: Important Facts to Note

Abbott Laboratories (ABT) is Facing Segment Competition and Sluggish Nutrition Recovery

Abbott Laboratories: A Strong Business At A Fair Price (NYSE:ABT)

What Makes Abbott Laboratories (ABT) an Attractive Opportunity?

Abbott: Quality Remains, But Exact Sciences Has Raised The Bar For Buy (NYSE:ABT)

Abbott Laboratories vs. Intuitive Surgical: Recent Quarterly Revenue Trends Reveal a Classic Investing Truth

Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?

Abbott Laboratories (ABT) Agrees To $385 Million Infant Formula Recall Settlement

Abbott Laboratories Agrees To Nearly $385 Million Settlement Over Infant Formula Allegations

Abbott (ABT) Rises As Market Takes a Dip: Key Facts

Abbott Laboratories jumps after six straight sessions of losses (ABT:NYSE)

Abbott to Pay $385 Million to Settle Infant Formula Safety Allegations

Abbott to Pay $385 Million to Settle Baby Formula Safety Allegations

Abbott to pay $385 million to settle allegations of contamination at a baby formula factory